CMS Modified NCD 7 for Thermogenic Therapy, Effective January 9, 2026 — What Billing Teams Need to Know

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 7, the National Coverage Determination governing thermogenic therapy (artificial fever induction), effective January 9, 2026. The policy maintains a blanket non-coverage position. No specific CPT or HCPCS codes are listed in the policy document.

This update is one of those policies that looks like a housekeeping move on the surface. It is — but the non-coverage language is unambiguous, and any thermogenic therapy billing submitted to Medicare will face claim denial. Here's what your billing team needs to understand before submitting claims related to this service.

---

Quick-Reference Table

Field	Detail Copy
Payer	CMS (Centers for Medicare & Medicaid Services)
Policy	Thermogenic Therapy — NCD 7
Policy Code	NCD 7
Change Type	Modified
Effective Date	2026-01-09
Impact Level	Low — blanket non-coverage, no reimbursement pathway exists
Specialties Affected	Internal medicine, infectious disease, rheumatology, neurology
Key Action	Do not submit thermogenic therapy claims to Medicare; flag any charge capture entries that reference artificial fever induction and remove them from your Medicare billing workflow

---

CMS Thermogenic Therapy Coverage Criteria and Medical Necessity Requirements 2026

The CMS thermogenic therapy coverage policy under NCD 7 in the Medicare system is straightforward: there is no covered indication. Full stop.

CMS defines thermogenic therapy as the artificial induction of fever to treat disease. The procedure has been in clinical use since 1919 — originally for resistant infectious diseases, rheumatoid arthritis, and Sydenham's chorea. That historical context matters because it explains why this NCD exists at all.

The policy language is direct. CMS states that thermogenic therapy "is not scientifically accepted for the treatment of any specific disease." The agency also notes that the widespread adoption of potent antibiotics has, for all practical purposes, replaced this modality entirely. No disease category qualifies for coverage under this policy.

Medical necessity is the threshold Medicare uses for almost every covered service. Under section 1862(a)(1) of the Social Security Act, a service must be reasonable and necessary for the treatment of an illness or injury. CMS has determined that thermogenic therapy does not meet that standard — under any indication, for any patient population.

This means prior authorization is irrelevant here. There is no prior authorization pathway for thermogenic therapy because there is no coverage pathway period. Submitting a prior auth request will not open a reimbursement door that the NCD has closed.

One important carve-out exists in the policy language. If a Medicare patient is admitted to an inpatient hospital setting for other covered services, that inpatient stay is still reimbursable — even if thermogenic therapy is administered during that stay. The hospital stay itself is not excluded. Only the thermogenic therapy line item is denied.

That distinction matters for your billing team. An inpatient stay for a patient receiving covered services stays billable. The thermogenic therapy charge does not get added to that claim.

---

CMS Thermogenic Therapy Exclusions and Non-Covered Indications

Every indication is excluded. The NCD does not carve out any subpopulation or clinical scenario where thermogenic therapy would be covered.

The policy specifically references the three historical indications for this treatment:

#	Excluded Procedure Copy
1	Resistant infectious diseases — not covered
2	Rheumatoid arthritis — not covered
3	Sydenham's chorea — not covered

CMS's reasoning is that the scientific foundation for thermogenic therapy does not exist. The advent of antibiotics rendered the infectious disease indication obsolete. The rheumatoid arthritis and Sydenham's chorea indications were never established through evidence that CMS recognizes as sufficient for coverage.

The phrase "regardless of the medium by which the fever is induced" is important. It means the delivery mechanism does not create a coverage distinction. Whether the fever is induced via hot baths, diathermy, or any other method, the non-coverage applies.

If you are billing for a related service that happens to involve heat application — physical therapy modalities, for example — do not conflate those services with thermogenic therapy. They are separate. This policy is specific to artificial fever induction as a treatment modality.

---

Coverage Indications at a Glance

---

CMS Thermogenic Therapy Billing Guidelines and Action Items 2026

The non-coverage position here is not new, but the January 9, 2026 effective date on this modification makes it the current governing version of the policy. Your billing team should treat this date as the reset point for any internal audits or payer correspondence referencing NCD 7.

Here are your action items:

Copy Action Items

If you are uncertain how this policy interacts with your payer mix — especially if you have hybrid Medicare Advantage contracts that may have their own thermogenic therapy language — talk to your billing consultant or compliance officer before January 9, 2026.

---

CPT, HCPCS, and ICD-10 Codes for Thermogenic Therapy Under NCD 7

Covered CPT Codes

The NCD 7 policy document does not list any covered CPT or HCPCS codes. There are no codes for thermogenic therapy billing that carry a covered status under this NCD.

Not Covered / Experimental Codes

The policy does not list specific CPT or HCPCS codes for thermogenic therapy billing. CMS has not assigned procedure codes to this modality in the NCD documentation. If your team identifies a code that appears to describe artificial fever induction on a claim, do not submit it to Medicare. The blanket non-coverage position under NCD 7 applies regardless of which code is used to describe the service.

Key ICD-10-CM Diagnosis Codes

No ICD-10-CM codes are listed in the NCD 7 policy document. The non-coverage determination is not diagnosis-specific — it applies across all diagnoses.

A practical note on the code gap: The absence of specific codes in this policy is not an accident. CMS's position is that this service has no covered application, so there is no need to enumerate codes. If your payer relations team or a MAC ever asks about coding for thermogenic therapy, the answer is that NCD 7 forecloses coverage at the service level, not the code level. That distinction matters in a coverage determination appeal.

---